← Back to all trials
Recruiting
NCT05018871
Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP
Conditions: Cerebral Palsy
Sex: All
Healthy volunteers: No
Phase: PHASE1
Enrollment: 15
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Location: Prodromos Stem Cell Institute Naples Florida
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured umbilical or placental derived mesenchymal stem cells for the treatment of Cerebral Palsy
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Cerebral Palsy
Exclusion Criteria:
* Active infection
* Active cancer
* Chronic multisystem organ failure
* Pregnancy
* Clinically significant Abnormalities on pre-treatment laboratory evaluation
* Medical condition that would (based on the opinion of the investigator) compromise patient's safety
* Previous organ transplant
* Seizure disorder
* Hypersensitivity to sulfur
Source: ClinicalTrials.gov (NCT05018871). StuddyBuddy aggregates publicly available trial information.
